Skip to content

TXI for the Recognition of Adenomas in Colonoscopy

Texture and Color Enhancement Imaging (TXI) Versus Standard White-light (WLI) Colonoscopy for Colorectal Adenoma Detection: a Multicenter, Randomized, Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04892966
Acronym
TRACK
Enrollment
747
Registered
2021-05-19
Start date
2021-04-01
Completion date
2022-09-30
Last updated
2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Polyp

Brief summary

This two parallel arms, randomized, multicenter trial is aimed at evaluating whether TXI is superior to WLI endoscopy in terms of adenoma detection. Secondary aims will be advanced adenoma detection rate, serrated polyp/adenoma detection rate, as well as procedure variables such as withdrawal time.

Interventions

DIAGNOSTIC_TESTTXI Light Imaging

Standard Colonoscopy using TXI imaging

DIAGNOSTIC_TESTWLI Imaging

Standard Colonoscopy using White Light Imaging

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- All \>40 years-old patients undergoing a colonoscopy for primary screening, Faecal Immunochemical Test (FIT) +, post-polypectomy surveillance

Exclusion criteria

* patients with personal history of colorectal cancer (CRC), or Inflammatory Bowel Disease (IBD). * Patients affected with Lynch syndrome or Familiar Adenomatous Polyposis. * patients with inadequate bowel preparation (defined as Boston Bowel Preparation Scale \<2 in any colonic segment). * patients with previous colonic resection. * patients on antithrombotic therapy, precluding polyp resection. * patients who were not able or refused to give informed written consent.

Design outcomes

Primary

MeasureTime frameDescription
Adenoma Detection Rate (ADR)1 yearthe proportion of participants with at least one adenoma (per-patient analysis)

Secondary

MeasureTime frameDescription
Advanced ADR1 yearas the proportion of participants with at least one advanced adenoma at a per-patient analysis
polyps, adenomas, advanced adenomas and Sessile Serrated Polyps (SSP) per subject1 yearthe total number of detected lesions in each group divided by the total number of participants (per polyp analysis)
proximal and flat adenomas detection rate1 yearthe total number of detected lesions in each group divided by the total number of participants (per-polyp analysis)
Withdrawal time1 yearTime from the start of the inspection at the cecum and the withdrawal of the colonoscope from the body of the patient.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026